Traditional Chinese medicinal composition for treating seasonal allergic rhinitis

Abstract

The invention relates to the technical field of traditional Chinese medicines, and especially relates to a traditional Chinese medicinal composition for treating seasonal allergic rhinitis. The traditional Chinese medicinal composition for treating seasonal allergic rhinitis is prepared by using the following medicinal materials, by weight, 10-15 parts of Blackberrylily Rhizome, 10-15 parts of apricot kernel, 4-8 parts of Radix Platycodonis, 10-15 parts of Aster tataricus, 10-15 parts of Common Coltsfoot Flower, 10-15 parts of (fried) lumbricus, 8-13 parts of gingko, 4-8 parts of Divaricate Saposhnikovia Root, 6-11 parts of cassia twig, 10-15 parts of white peony root, 6-11 parts of Chinese angelica, 6-11 parts of licorice root, 8-13 parts of Negundo Chastetree Fruit, 12-18 parts of perilla fruit, 6-11 parts of lily, 10-15 parts of Polygonatum sibiricum, 10-15 parts of Herba Centipedae, 12-18 parts of Manchurian wildginger, 6-11 parts of Rhizoma Anemarrhenae, 10-15 parts of datura flower and 12-18 parts of Chinese ilex. The composition is mainly used for treating the seasonal allergic rhinitis, especially progressive seasonal allergic rhinitis difficult to cure clinically; and years of clinic application researches show that the total effective rate of the composition on asthmatic suffocating caused by the seasonal allergic rhinitis, seasonal aggravated rhinitis and allergic trachitis can reach 100%.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating seasonal allergic asthma. Background technique [0002] Seasonal allergic asthma is a chronic airway inflammation involving a variety of cells, especially mast cells, eosinophils and T lymphocytes. In susceptible persons, this inflammation can cause recurrent symptoms such as wheezing, shortness of breath, chest tightness, and / or coughing, which mostly occur at night and early morning, and the airway is more responsive to various stimuli. But the symptoms can be relieved by themselves or by treatment. Over the past ten years, the prevalence and mortality of asthma in the United States, the United Kingdom, Australia, New Zealand and other countries have been on the rise. There are about 100 million asthma patients in the world, and it has become a major chronic disease that seriously threatens public he...

AI Technical Summary

Problems solved by technology

Injection desensitization treatment cycle is long, usually at least 2 to 3 years, long-term injection will bring some pain